FBXO3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.153000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.795200E-01
Normal-vs-Stage2
1.509250E-01
Normal-vs-Stage3
1.745900E-02
Normal-vs-Stage4
5.216200E-01
Stage1-vs-Stage2
3.109200E-01
Stage1-vs-Stage3
3.420200E-02
Stage1-vs-Stage4
9.587400E-01
Stage2-vs-Stage3
5.281100E-03
Stage2-vs-Stage4
4.386600E-01
Stage3-vs-Stage4
6.484000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.894630E-01
Normal-vs-AfricanAmerican
6.873600E-01
Normal-vs-Asian
1.530990E-01
Caucasian-vs-AfricanAmerican
3.351800E-01
Caucasian-vs-Asian
6.719600E-01
AfricanAmerican-vs-Asian
3.427600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.290000E-01
Normal-vs-Female
2.154800E-01
Male-vs-Female
7.469000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.985000E-01
Normal-vs-Age(41-60Yrs)
4.253400E-01
Normal-vs-Age(61-80Yrs)
1.704220E-01
Normal-vs-Age(81-100Yrs)
6.451600E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.402600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.581600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.858800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.648000E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.345900E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.305200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.040200E-01
Normal-vs-Daily Drinker
1.383590E-02
Normal-vs-Weekly Drinker
9.183900E-02
Normal-vs-Occasional Drinker
9.113000E-01
Normal-vs-Social Drinker
1.865360E-01
Non Drinker-vs-Daily Drinker
1.376600E-01
Non Drinker-vs-Weekly Drinker
2.927800E-01
Non Drinker-vs-Occasional Drinker
9.623700E-02
Non Drinker-vs-Social Drinker
8.220400E-01
Daily Drinker-vs-Weekly Drinker
9.437600E-01
Daily Drinker-vs-Occasional Drinker
1.874390E-02
Daily Drinker-vs-Social Drinker
1.467160E-01
Weekly Drinker-vs-Occasional Drinker
4.848300E-02
Weekly Drinker-vs-Social Drinker
3.094400E-01
Occasional Drinker-vs-Social Drinker
1.540390E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.961600E-02
Normal-vs-Grade 2
1.501820E-03
Normal-vs-Grade 3
1.983530E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.334800E-01
Grade 1-vs-Grade 3
7.237600E-01
Grade 1-vs-Grade 4
2.961600E-02
Grade 2-vs-Grade 3
4.941400E-01
Grade 2-vs-Grade 4
1.501820E-03
Grade 3-vs-Grade 4
1.983530E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.043600E-02
Normal-vs-NonDiabetic
2.230600E-01
Diabetic-vs-NonDiabetic
1.426790E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.974000E-02
Normal-vs-NoPancreatitis
1.851750E-01
Pancreatitis-vs-NoPancreatitis
4.358800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.746600E-01
Normal-vs-N1
1.690390E-01
N0-vs-N1
3.373800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.299000E-01
Normal-vs-TP53-NonMutant
4.688800E-01
TP53-Mutant-vs-TP53-NonMutant
9.581000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
